NCT00540007 - Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2007

Primary Completion Date

September 1, 2016

Study Completion Date

September 1, 2016

Conditions

Hodgkin Disease

Interventions

DRUG

Lenalidomide

Trial Locations (5)

Wake Forest University Medical School, Winston-Salem

Ohio State University, Columbus

Medical College of Wisconsin, Milwaukee

Washington University, St Louis

Hackensack University Medical Center, Hackensack